GMO GlobalSign
5.12.2023 12:07:13 CET | ACCESS Newswire | Press release
2023 was a year of expansion of the Atlas platform and increasing focus on certificate automation
BOSTON, MA / ACCESSWIRE / December 5, 2023 / GMO GlobalSign, Inc., a global Certificate Authority (CA) and leading provider of identity security, digital signing and IoT solutions, today announced the company's business highlights for 2023. A top focus for GMO GlobalSign this year has been the continued expansion of the Atlas Platform as well as an increasing call for enterprises to automate certificate management.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Atlas Platform Growth: GMOGlobalSign's digital identity platform, Atlas, was integrated with leading digital workflow company ServiceNow®. With GMO GlobalSign's PKIaaS Connector for ServiceNow, certificate management is made simpler for all ServiceNow users allowing enterprises to manage their digital certificate requests, all within their existing ServiceNow instance.
GMO GlobalSign also announced the availability of a new type of seal based on a qualified certificate. Qualified Trust Seals by DSS enable customers to quickly deploy seals at a high volume. Available through the Atlas platform, the new Qualified Trust Seals offering was created in response to customer requests for a fully automated remote signing service meeting the requirements of European Union Trust Lists. Based on our popular Digital Signing Service (DSS), GMO GlobalSign's Qualified Trust Seals allows for quick deployment, the perfect answer for organizations looking for a stress-free integration with APIs using the open source EUTL identity framework.
In addition, GlobalSign Atlas Discovery certificate scanning and reporting tool was made available. With the help of Atlas Discovery, organizations can do everything from having full accountability of all certificates, monitor network health, checking SSL/TLS certificates for common errors to understanding certificate expiration status to prevent outages.
Certificate Automation: GMO GlobalSign announced the expansion of our Automated Certificate Management Environment (ACME) service beyond Domain Validated (DV) to support Organization Validated (OV) SSL/TLS certificates, for instant verification of a company or organization.ACME OV represents a great next step towards automating SSL/TLS lifecycles and breaking into larger automation strategies for managing an organization's entire Public Key Infrastructure (PKI). This delivers strong protection for websites and businesses by activating HTTPS, reassuring an organization can completely secure all internal, as well as external communications.
Qualified Signing Service Launch: The company launched a cloud-based Qualified Signing Service (QSS) for qualified electronic signatures and seals. QSS complies with eIDAS (electronic IDentification, Authentication and trust Services), an EU regulation for electronic identification and trust services. GMO GlobalSign's Qualified Signing Service allows businesses to use mobile devices to authenticate compliantly to the QSS service enabling signatures by employees wherever they are in the world. QSS is already off to a great start, especially with European service providers who view this solution as an important new product for their customers.
Other 2023 highlights include:
- Digital signature and timestamp growth was significant. From January through early December, customers utilized our Digital Signing Service for more than 45 million signatures, while nearly 50 million timestamps were applied to a broad array of documents.
- GMO GlobalSign established partnerships with airSlate, essendi it and eXsolut GmbH.
- Our Auto Enrollment Gateway (AEG) automated certificate management tool was upgraded. The latest version offers an enhanced integration with Microsoft Intune that allows an organization to quickly provision certificates in seconds with manual intervention.
GMO GlobalSign has also worked throughout the year to impress upon companies the increasing need to automate certificate management. With decreasing certificate lifecycles - while company's endpoints are increasing - certificate management steadily becomes more difficult to manage without automation. To not do so is a risk for expirations, or worse.
In addition, the company announced achieving ISO 27701:2019 for Privacy Information Management System (PIMS) and ISO 27017:2015 for Cloud Security. GMO GlobalSign is the only certificate authority in the world to achieve this level of ISO certification. These certifications provide our customers with a guarantee that we have implemented the Information Technology industry's best-practice security methods.
"This was a year marked by a great deal of product expansion but also a tremendous focus on the need to automate the full lifecycle of certificate management. We also took steps to meet customer requests and launched new offerings like the Qualified Signing Service and Qualified Trust Seals," said Lila Kee, General Manager of the Americas, and Chief Product Officer for GMO GlobalSign. "It has been especially rewarding to see the growth of the Atlas platform. We are steadily adding capabilities which makes it a powerful tool for organizations to successfully manage their PKI."
About GMO GlobalSign
As one of the world's most deeply-rooted certificate authorities, GMO GlobalSign is the leading provider of trusted identity and security solutions enabling businesses, large enterprises, cloud-based service providers, and IoT innovators worldwide to conduct secure online communications, manage millions of verified digital identities and automate authentication and encryption. Its high-scale Public Key Infrastructure (PKI) and identity solutions support the billions of services, devices, people, and things comprising the IoT. GMO GlobalSign is a subsidiary of GMO GlobalSign Holdings, K.K., a member of the Japan-based GMO Internet Group, has offices in the Americas, Europe and Asia. For more information, visit https://www.globalsign.com.
Media Relations Contact
Amy Krigman
Director of Public Relations - West Region
Phone: 603-570-7060
Email: amy.krigman@globalsign.com
SOURCE: GMO GlobalSign
View source version on accesswire.com:
https://www.accesswire.com/813107/leading-certificate-authoritygmoglobalsigns-year-in-review
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Fermi Announces New Agreements with Investment-Grade Hyperscaler and Third Quarter 2026 Financial Results12.11.2026 13:00:00 CET | Press release
DALLAS, TX / ACCESS Newswire / November 12, 2026 / Fermi Inc. (NASDAQ:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), today announced its third quarter 2026 financial results and multiple new agreements with an investment-grade hyperscaler to advance 600 megawatts ("MW") of power capacity at Project Matador. A conference call is scheduled for 9 a.m. Eastern Time / 2 p.m. British Time today, November 12, 2026. Accompanying slides and prepared remarks can be found at https://investor.fermiamerica.com. Participation details are included in this release. "Hyperscalers want sites that are ready with permitted power, and Fermi's Project Matador is one of few that can meet that demand today," said Lee McIntire, Fermi Chief Executive Officer. "Our headstart in speed to power is a key reason an investment-grade hyperscaler has signed up for 600 megawatts and committed more than $200 million up front to accelerate construction at Project Matador with an additional $90 mi
Nexteer Announces First Share Repurchase Programme of Up to US$60 Million12.11.2026 01:40:00 CET | Press release
HONG KONG, HK / ACCESS Newswire / November 11, 2026 / Nexteer Automotive today announced that its Board of Directors has approved, the Company's first share repurchase programme of up to US$60 million, equivalent to approximately HK$471 million. The programme reflects the Board's confidence in Nexteer's business and long-term prospects. The Group's strong liquidity position supports returning capital to shareholders while continuing to invest in the business and its future development. Disciplined Capital Allocation The programme complements Nexteer's dividend distributions and represents a further step in returning capital to shareholders. It follows the dividend paid out in July 2026 of approximately US$46 million, representing 45% of the Company's net income attributable to shareholders for the year ending December 31, 2025 -and the highest dividend payout ratio in the Company's history. Nexteer remains committed to disciplined capital allocation, balancing investment in the busines
GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents10.11.2026 15:30:00 CET | Press release
SAN FRANCISCO, CA / ACCESS Newswire / November 10, 2026 / GoodData.AI, the open agentic analytics platform, today launched the Agentic Serving Plane, a governed execution layer designed for the high-concurrency, context-rich data workloads created by AI agents. The Agentic Serving Plane sits between enterprise data platforms and the applications, analytics experiences and agents that consume them. It provides workload serving, business semantics, contextual grounding, access control, and AI execution services through a common governed layer. The current enterprise data infrastructure was designed primarily for humans: occasional queries, predictable workloads, and access by known users. AI agents operate differently. A single business task can generate tens or hundreds of short-lived data operations as an agent investigates, reasons, and decides what to ask next. When many agents operate simultaneously, intermittent human querying becomes continuous, high-concurrency agentic demand. Ag
Envision Pharma Group appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian10.11.2026 15:00:00 CET | Press release
FAIRFIELD, CT / ACCESS Newswire / November 10, 2026 / Envision Pharma Group (Envision), a global, technology-enabled solutions partner to the life sciences industry, has appointed Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian. Siino will lead a team providing best-in-class launch and revenue management services to the biopharma community. Pharma and biotech companies across the industry seek suppliers who can support them from their earliest stages, often before they have built in-house commercial, market access, and revenue management capabilities. Two Labs provides commercialization services and consulting support as these companies prepare for and execute successful launches; Riparian offers consulting, managed services, and technology to manage and protect revenue as their therapies reach patients. Together, Envision's Two Labs and Riparian businesses offer a single, connected solution spanning launch and beyond. Under Siino's leadership, clients wi
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations10.11.2026 14:00:00 CET | Press release
LINCOLN, NE / ACCESS Newswire / November 10, 2026 / Securitas Healthcare, a leading provider of real-time visibility and protection solutions for the healthcare industry, today announced the next generation of its MobileView® Real-Time Location System (RTLS) platform. The expanded platform introduces MobileView Cloud, new solution capabilities, enhanced user experiences, and flexible deployment, technology, and integration options that help healthcare organizations transform real-time visibility into operational intelligence. As health systems navigate workforce shortages, capacity constraints, and growing demands for efficiency and better patient experiences, timely access to operational and clinical information has become essential to managing increasingly complex care environments. Today's RTLS platforms provide the visibility and intelligence needed to improve patient throughput, enhance safety, optimize resource utilization, and support the connected operations required to enable
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
